New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy

Diabetic nephropathy (DN) is a severe complication of diabetes and serves as the leading cause of chronic renal failure. In the past decades, angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin II receptor blockers (ARBs) based first-line therapy can slow but cannot stop the progression of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jia, Zhanjun, Sun, Ying, Yang, Guangrui, Zhang, Aihua, Huang, Songming, Heiney, Kristina Marie, Zhang, Yue
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2014
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3927865/
https://ncbi.nlm.nih.gov/pubmed/24624137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/818530
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados